- ISIN
- US29415F1049
- CUSIP
- 29415F104
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Sep 18, 2019
Highlights
- Market Cap
- $4.44B
- Enterprise Value
- $4.99B
- EPS (TTM)
- $0.40
- PE Ratio
- 67.60
- PEG Ratio
- 0.81
- Total Revenue (TTM)
- $2.81B
- Gross Profit (TTM)
- $1.55B
- EBITDA (TTM)
- $342.00M
- Year Range
- $18.77 - $30.42
- Target Price
- $27.00
- ROA (TTM)
- 1.21%
- ROE (TTM)
- 2.20%
- Avg. Volume (1M)
- 3M
- Avg. Volume Value (1M)
- $70.68M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
NVST Performance Chart
Envista Holdings Corporation (NVST) is up 25.8% since the beginning of the year. At $27 per share, NVST is trading 10.2% below its 52-week high of $30. Investors who bought $1,000 worth of NVST shares 5 years ago would now be looking at an investment worth $634.
Loading charts...
Compare this symbol against anything
Returns By Period
Envista Holdings Corporation (NVST) has returned 25.79% so far this year and 31.11% over the past 12 months.
Envista Holdings Corporation
- 1D
- -1.69%
- 1M
- -1.16%
- 6M
- 16.36%
- YTD
- 25.79%
- 1Y
- 31.11%
- 3Y*
- -7.05%
- 5Y*
- -8.71%
- 10Y*
- —
- ALL TIME*
- 0.92%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
NVST Monthly Returns History
Based on dividend-adjusted daily data since Sep 18, 2019, NVST's average daily return is +0.04%, while the average monthly return is +0.64%. At this rate, an investment would double in approximately 9.1 years.
Historically, 54% of months were positive and 46% were negative. The best month was Apr 2020 with a return of +30.3%, while the worst month was Mar 2020 at -41.1%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 6 months.
On a daily basis, NVST closed higher 49% of trading days. The best single day was Feb 6, 2026 with a return of +17.8%, while the worst single day was Mar 18, 2020 at -23.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.11% | 24.46% | -13.15% | 2.25% | -9.21% | 11.89% | 3.64% | 25.79% | |||||
| 2025 | 6.38% | -2.63% | -13.61% | -6.84% | 13.62% | 6.95% | -3.33% | 12.12% | -3.82% | -0.10% | 2.70% | 3.88% | 12.55% |
| 2024 | -2.33% | -12.13% | 3.54% | -7.95% | -1.63% | -14.10% | 2.65% | 6.97% | 8.21% | 6.12% | 6.29% | -13.46% | -19.83% |
| 2023 | 15.80% | -0.85% | 5.74% | -5.85% | -17.15% | 6.11% | 1.68% | -6.95% | -12.93% | -16.54% | -2.49% | 6.04% | -28.54% |
| 2022 | -4.04% | 11.01% | 1.48% | -18.66% | 8.63% | -10.46% | 5.47% | -8.76% | -11.54% | 0.61% | 3.36% | -1.32% | -25.28% |
| 2021 | 5.37% | 8.44% | 5.86% | 6.08% | 0.83% | -0.99% | -0.30% | -0.67% | -2.29% | -6.48% | -0.77% | 16.13% | 33.59% |
Benchmark Metrics
Envista Holdings Corporation has an annualized alpha of -7.25%, beta of 1.07, and R2 of 0.29 versus S&P 500 Index. Calculated based on daily prices since September 18, 2019.
- This stock participated in 120.38% of S&P 500 Index downside but only 70.35% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.29 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -7.25%
- Beta
- 1.07
- R²
- 0.29
- Upside Capture
- 70.35%
- Downside Capture
- 120.38%
Return for Risk
Risk / Return Rank
NVST ranks 77 for risk / return — above 77% of stocks peers on PortfoliosLab. Its historical combined result is above most peers.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Envista Holdings Corporation (NVST) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVST | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.28 | ||
| Sortino ratioReturn per unit of downside risk | -0.03 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.25 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.72 | 2.00 | -0.28 |
| Martin ratioReturn relative to average drawdown | 4.05 | 8.49 | -4.44 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Envista Holdings Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Envista Holdings Corporation was 71.00%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current Envista Holdings Corporation drawdown is 46.35%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-71.00%Apr 2025 | 3y 18d | — | 4y 4moMar 2022 - now | 2025 selloff2025 |
-64.13%Mar 2020 | 2mo | 9mo 13d | 11mo 13dJan 2020 - Dec 2020 | COVID crash2020 |
-17.04%Oct 2021 | 5mo 20d | 1mo 27d | 7mo 17dMay 2021 - Dec 2021 | — |
-11.54%Mar 2022 | 18d | 11d | 29dFeb 2022 - Mar 2022 | Bear market2022 |
-11.42%Jan 2022 | 1mo | 14d | 1mo 14dDec 2021 - Feb 2022 | Bear market2022 |
Drawdown Indicators
| NVST | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.00% | -56.78% | -14.22% |
Max Drawdown (1Y)Largest decline over 1 year | -25.97% | -9.10% | -16.87% |
Max Drawdown (3Y)Largest decline over 3 years | -57.77% | -18.90% | -38.87% |
Max Drawdown (5Y)Largest decline over 5 years | -71.00% | -25.43% | -45.57% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -46.35% | -1.58% | -44.77% |
Average DrawdownAverage peak-to-trough decline | -35.29% | -10.70% | -24.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.04% | 2.14% | +8.90% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Envista Holdings Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Envista Holdings Corporation is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for NVST, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, NVST has a P/E ratio of 67.6. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for NVST compared to other companies in the Medical Instruments & Supplies industry. NVST currently has a PEG ratio of 0.8. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for NVST relative to other companies in the Medical Instruments & Supplies industry. Currently, NVST has a P/S ratio of 1.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for NVST in comparison with other companies in the Medical Instruments & Supplies industry. Currently, NVST has a P/B value of 1.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with NVST
Add Envista Holdings Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with NVST